Explore evidence

1 µMTafenoquine at 1µM potently inhibited both Plasmodium vivax hypnozoites and schizonts.

Malipaludismepublished 2023BMC infectious diseaseseurope_pmcdocument of 4 observations

3,120 parasites/μLLa parasitémie moyenne pour les infections à Plasmodium malariae était de 3 120 parasites/μL.

MalipaludismeHAL · Unilimdocument of 214 observations

0.24 hazard_ratioT cell responses to TRAP peptides 21 to 30 were significantly associated with protection, with a hazard ratio of 0.24.

Malipaludismepublished 2015Science translational medicineeurope_pmcdocument of 2 observations

75 %The median coverage rate for long-lasting insecticidal net (LLIN) routine distribution for the 75 health districts and the 5 epidemic years was 75.0%.

MalipaludismeHAL · Unilimdocument of 111 observations

0.06 %P. ovale prevalence was 0.06% in active screening.

Malipaludismepublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations

30 %There was at least a 30% reduction in the point estimates for the prevalence of severe wasting in the combined group compared to the other two groups in 2017 and 2018.

Burkina Faso · Malipaludismeobserved 2017 and 2018published 2022Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/s12936-022-04077-x

49 %Eighty-one (49%) of 164 malaria cases shed CMV at day 0.

Malicytomegalovirus (CMV) · paludismepublished 2016Journal of clinical virology : the official publication of the Pan American Society for Cleurope_pmcdocument of 6 observations

41.91 %P. falciparum représentait 82 des 179 infections (41,91 %).

MalipaludismeHAL · Unilimdocument of 214 observations

6,236 childrenThe first round of seasonal malaria chemoprevention treated 6,236 children under 5 years old from July 29 to August 2, 2024.

Malipaludismeobserved July 29 to August 2, 2024HAL · Unilimdocument of 80 observations

44 %Distribution methods have been diversified with school and community distribution to increase the universal coverage rate, which remains low at 44%.

MalipaludismeHAL · Unilimdocument of 95 observations

1.15 %Plasmodium malariae avait une prévalence de 1,15 % lors du dépistage actif.

MalipaludismeHAL · Unilimdocument of 214 observations

4.9 %In Mali, parasite prevalence increased from 4.9% to 15.3% after seasonal malaria chemoprevention in 2015.

Malipaludismeobserved 2015HAL · Unilimdocument of 110 observations

30 %La prévalence du paludisme chez les enfants de moins de cinq ans au Mali était de 30 % à Sikasso en 2018.

Malipaludismeobserved 2018HAL · Unilimdocument of 214 observations

40 %Plasmodium falciparum infection occurred in 30 participants (40%) in the 300-mg L9LS group.

Malipaludismepublished 2024The New England journal of medicineeurope_pmcdocument of 7 observations

45.5 %Malaria infection prevalence was 45.5% when assessed by microscopy in children aged less than 15 years in Dabbis sub-prefecture, Boke region, Guinea.

Malipaludismeobserved 2017published 2021The Journal of parasitologyeurope_pmcdocument of 7 observations

3 %Higher proportions of non-falciparum species were detected by qPCR than microscopy: 3% against 0% for Plasmodium ovale.

Malipaludismeobserved 2017, 2018published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 6 observationsDOI 10.4269/ajtmh.20-0593

Multiplicity of infection based on MSP-1(19) was higher at the beginning of the malaria transmission season in Mali.

Malipaludismepublished 2007PLoS MedicineOpenAlexdocument of 5 observationsDOI 10.1371/journal.pmed.0040093

1.91 %Chez les enfants âgés de 1 à 4 ans, 1,91 % présentaient une hyperparasitémie (≥200 000 parasites/μL).

MalipaludismeHAL · Unilimdocument of 214 observations

67 Health Districts67 Health Districts in Mali were identified for intermittent preventive treatment in pregnancy (IPTp), including community IPTp.

MalipaludismeHAL · Unilimdocument of 95 observations

0.5 µMPlasmodium vivax schizont stages were fully susceptible to the PI4K-specific inhibitor KDU691 at 0.5µM.

Malipaludismepublished 2023BMC infectious diseaseseurope_pmcdocument of 4 observations

65 %_greater_protectionThe seasonal RTS,S plus SMC trial in Mali and Burkina Faso found that the combination of seasonal RTS,S vaccine and SMC provided around 60%–70% greater protection against uncomplicated and severe malaria and deaths from malaria, when compared with SMC or RTS,S alone.

Burkina Faso · MalipaludismeHAL · Unilimdocument of 8 observations

50 %Un plus grand nombre de porteurs de Plasmodium ovale (50 %) présentaient une anémie (taux d’hémoglobine < 11 g/dL).

MalipaludismeHAL · Unilimdocument of 214 observations

25 %In Mali in 2023, malaria accounted for 25% of mortality at the national level.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

98.5 %A randomized, phase 3 study comparing artemether-lumefantrine (AL) Dispersible to crushed AL tablets in 899 African children reported a PCR-corrected cure rate of 98.5% at day 28 for crushed AL tablets.

Malipaludismepublished 2015Antimicrobial agents and chemotherapyeurope_pmcdocument of 3 observations

85 per_100Au Mali, P. falciparum est responsable de 85 à 95 % des cas de paludisme rapportés selon la période de l’année.

MalipaludismeHAL · Unilimdocument of 214 observations